Dexcom Raises Sales Expectations, Discusses G8 Plans

Dexcom raises sales expectations, discusses G8 plans

Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and over-the-counter devices to drive future growth.

Dexcom beats Street in Q2, raises guidance

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast. The company also announced a planned CEO transition — read more about that HERE. Shares of DXCM sat unchanged at $89.06 apiece in post-market trading today. The San Diego-based continuous glucose monitor maker reported profits of $179.8 million. That equals 45¢ per share on sales of $1.16 billion for the three months ended June 30, …